Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Press Release: Ryan Mackenzie Introduces Bipartisan Bill on Prescription Drug Price Transparency

None

Bipartisan bill would increase drug pricing transparency by requiring PBMs to disclose net effective costs and promote competition.

Quiver AI Summary

Bill introduced: Congressman Ryan Mackenzie and four other House members introduced the bipartisan Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026. The bill is described as an effort to increase transparency and competition in the pharmacy benefit manager, or PBM, market and to help lower prescription drug costs.

What the measure would do: According to the release, the legislation would require more disclosure of the "net effective cost" of drugs, including rebates, discounts, fees and other price concessions. Supporters say this would make PBM bids easier to compare and could add accountability in Medicare, Medicare Advantage and employer health plans.

Lawmakers' comments: The sponsors said the measure builds on earlier bipartisan work on PBM oversight. Each cited the need for clearer pricing and lower costs for patients and health plans.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Ryan Mackenzie Fundraising

Ryan Mackenzie Fundraising

Ryan Mackenzie recently disclosed $303.0K of fundraising in a Q2 FEC disclosure filed on July 15th, 2026. This was the 333rd most from all Q2 reports we have seen this year. 59.7% came from individual donors.

Mackenzie disclosed $286.6K of spending. This was the 371st most from all Q2 reports we have seen from politicians so far this year.

Mackenzie disclosed $2.9M of cash on hand at the end of the filing period. This was the 140th most from all Q2 reports we have seen this year.

You can see the disclosure here, or track Ryan Mackenzie's fundraising on Quiver Quantitative.

Ryan Mackenzie Net Worth

Quiver Quantitative estimates that Ryan Mackenzie is worth $1.3M, as of September 17th, 2026. This is the 312th highest net worth in Congress, per our live estimates.

Mackenzie has approximately $642.2K invested in publicly traded assets which Quiver is able to track live.

You can track Ryan Mackenzie's net worth on Quiver Quantitative's politician page for Mackenzie.

Ryan Mackenzie Bill Proposals

Here are some bills which have recently been proposed by Ryan Mackenzie:

  • H.R.10381: To establish certain requirements with respect to judicial actions challenging a State congressional redistricting plan, and for other purposes.
  • H.R.10369: To amend title XVIII of the Social Security Act, and the Employee Retirement Income Security Act of 1974, to create certain requirements with respect to pharmacy benefit managers.
  • H.R.9989: CITE Act of 2026
  • H.R.9723: Fit Future Act
  • H.R.9630: BILL Drivers Act
  • H.R.9410: VA Education Oversight Improvement Act

You can track bills proposed by Ryan Mackenzie on Quiver Quantitative's politician page for Mackenzie.

2026 Pennsylvania's 7th Congressional District Election

There has been approximately $60,968,989 of spending in Pennsylvania's 7th congressional district elections over the last two years, per our estimates.

Approximately $45,981,875 of this has been from outside spending by PACs and Super PACs. Some of the groups who are spending money in this race include:

The rating for this race is currently "Toss Up".

You can track this election on our matchup page for the 2026 Pennsylvania's 7th congressional district election.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles